A cross-sectional study of changes in markers of immunological effects and lung health due to exposure to multi-walled carbon nanotubes

Nanotoxicology

Volumn 11, Issue 3, 2017, Pages 395-404

  Vlaanderen, Jelle ^a   Pronk, Anjoeka ^b   Rothman, Nathaniel ^c   Hildesheim, Allan ^c   Silverman, Debra ^c   Hosgood, H Dean ^d   Spaan, Suzanne ^b   Kuijpers, Eelco ^b   Godderis, Lode ^e,f   Hoet, Peter ^e   Lan, Qing ^c   Vermeulen, Roel ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f EXTERNAL SERVICE FOR PREVENTION AND PROTECTION AT WORK   (Belgium)

Author keywords

Carbon nanotubes; immune markers; lung health; nano particles; occupational exposure

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; EOTAXIN 2; EPIDERMAL GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE CHEMOTACTIC PROTEIN 2; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 16; INTERLEUKIN 29; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 7; INTERLEUKIN RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MULTI WALLED NANOTUBE; SECONDARY LYMPHOID TISSUE CHEMOKINE; SERUM AMYLOID A; SOLUBLE INTERLEUKIN 1 RECEPTOR; STEM CELL FACTOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; THROMBOPOIETIN; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; CARBON NANOTUBE; NITRIC OXIDE;

ADULT; AGE; ARTICLE; BASOPHIL; BLOOD CELL COUNT; BODY MASS; CLINICAL ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FRACTIONAL EXHALED NITRIC OXIDE; HEMATOCRIT; HUMAN; IMMATURE PLATELET FRACTION; IMMATURE RETICULOCYTE FRACTION; IMMUNE INJURY; IMMUNOTOXICITY; LEUKOCYTE COUNT; LUNG FUNCTION; LUNG INJURY; LUNG TOXICITY; LYMPHOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEASUREMENT REPEATABILITY; MONOCYTE; NANOTOXICOLOGY; NEUTROPHIL COUNT; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RED BLOOD CELL DISTRIBUTION WIDTH; REPLICATION STUDY; RESPIRATORY TRACT PARAMETERS; RETICULOCYTE COUNT; RETICULOCYTE HEMOGLOBIN CONTENT; SENSITIVITY ANALYSIS; SEX; SMOKING; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION AND CHARACTERISTICS; THROMBOCYTE VOLUME; WORKER; BREATH ANALYSIS; DRUG EFFECTS; IMMUNE SYSTEM; LUNG; METABOLISM;

ADULT; BIOMARKERS; BREATH TESTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNE SYSTEM; LUNG; MALE; NANOTUBES, CARBON; NITRIC OXIDE; OCCUPATIONAL EXPOSURE;

EID: 85017032281     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390.2017.1308031     Document Type: Article

References (47)

1. Aka PV, Kemp TJ, Rabkin CS, Shiels MS, Polizzotto MN, Lauria C, et al. 2015. A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcoma. J Infect Dis 211:226–9.
2. Barclay C, Li AW, Geldenhuys L, Baguma-Nibasheka M, Porter GA, Veugelers PJ, et al. 2005. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin Cancer Res 11:7683–91.
3. Bekker C, Kuijpers E, Brouwer DH, Vermeulen R, Fransman W., 2015. Occupational exposure to nano-objects and their agglomerates and aggregates across various life cycle stages; a broad-scale exposure study. Ann Occup Hyg 59:681–704.
4. Benjamini Y, Hochberg Y., 1995. Controlling the false discovery rate:a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289–300.
5. Carolan BJ, Hughes G, Morrow J, Hersh CP, O’Neal WK, Rennard S, et al. 2014. The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir Res 15:127.
6. Chaturvedi AK, Kemp TJ, Pfeiffer RM, Biancotto A, Williams M, Munuo S, et al. 2011. Evaluation of multiplexed cytokine and inflammation marker measurements:a methodologic study. Cancer Epidemiol Biomarkers Prev 20:1902–11.
7. Chaudhuri N, Jary H, Lea S, Khan N, Piddock KC, Dockrell DH, et al. 2012. Diesel exhaust particle exposure in vitro alters monocyte differentiation and function. PLoS One 7:e51107.
8. Chen R, Zhang L, Ge C, Tseng MT, Bai R, Qu Y, et al. 2015. Subchronic toxicity and cardiovascular responses in spontaneously hypertensive rats after exposure to multiwalled carbon nanotubes by intratracheal instillation. Chem Res Toxicol 28:440–50.
9. Crane-Godreau MA, Maccani MA, Eszterhas SK, Warner SL, Jukosky JA, Fiering S., 2009. Exposure to cigarette smoke disrupts CCL20-mediated antimicrobial activity in respiratory epithelial cells. Open Immunol J 2:86–93.
10. Dweik R, Boggs P., 2011. An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 184:602–15.
11. Fatkhutdinova LM, Khaliullin TO, Vasil’yeva OL, Zalyalov RR, Mustafin IG, Kisin ER, et al. 2016. Fibrosis biomarkers in workers exposed to MWCNTs. Toxicol Appl Pharmacol 299:125–31.
12. Fatkhutdinova LM, Khaliullin TO, Vasilyeva OL, Zalyalov RR, Valeeva IK, Mustafin IG, et al. 2013. Pilot cross-sectional study for potential fibrogenic risk assessment in real multiwalled carbon nanotube aerosol exposure at the workplaces. Kazan meditsinskiy Z 94:770–4.
13. Frampton MW, Bausch J, Chalupa D, Hopke PK, Little EL, Oakes D, et al. 2012. Effects of outdoor air pollutants on platelet activation in people with type 2 diabetes. Inhal Toxicol 24:831–8.
14. Gibson C, Berliner N., 2014. How we evaluate and treat neutropenia in adults. Blood 124:1251–8. quiz 1378.
15. Goto Y, Ishii H, Hogg JC, Shih C-H, Yatera K, Vincent R, et al. 2004. Particulate matter air pollution stimulates monocyte release from the bone marrow. Am J Respir Crit Care Med 170:891–7.
16. Han SG, Andrews R, Gairola CG., 2010. Acute pulmonary response of mice to multi-wall carbon nanotubes. Inhal Toxicol 22:340–7.
17. Ishii H, Hayashi S, Hogg JC, Fujii T, Goto Y, Sakamoto N, et al. 2005. Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Respir Res 6:87.
18. Kim JS, Song KS, Yu IJ., 2015. Multiwall carbon nanotube-induced DNA damage and cytotoxicity in male human peripheral blood lymphocytes. Int J Toxicol 35:27–37.
19. Kuempel E, Jaurand M, Møller P, Morimoto Y, Kobayashi N, Pinkerton K, et al. 2017. Evaluating the key evidence and data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans. Crit Rev Toxicol 47:1–58. doi:10.1080/10408444.2016.1206061
20. Kuijpers E, Bekker C, Fransman W, Brouwer DH, Tromp P, Vlaanderen J, et al. 2015. Occupational exposure to multi-walled carbon nanotubes during commercial production synthesis and handling. Ann Occup Hyg 60:305–17.
21. Lee JS, Choi YC, Shin JH, Lee JH, Lee Y, Park SY, et al. 2015. Health surveillance study of workers who manufacture multi-walled carbon nanotubes. Nanotoxicology 9:802–11.
22. Li Y, Rittenhouse-Olson K, Scheider WL, Mu L., 2012. Effect of particulate matter air pollution on C-reactive protein:a review of epidemiologic studies. Rev Environ Health 27:133–49.
23. Liao H-Y, Chung Y-T, Lai C-H, Lin M-H, Liou S-H., 2014a. Sneezing and allergic dermatitis were increased in engineered nanomaterial handling workers. Ind Health 52:199–215.
24. Liao H-Y, Chung Y-T, Lai C-H, Wang S-L, Chiang H-C, Li L-A, et al. 2014b. Six-month follow-up study of health markers of nanomaterials among workers handling engineered nanomaterials. Nanotoxicology 8:100–10.
25. Liou S-H, Tsai CSJ, Pelclova D, Schubauer-Berigan MK, Schulte PA., 2015. Assessing the first wave of epidemiological studies of nanomaterial workers. J Nanopart Res 17:413.
26. Malinovschi A, Janson C, Holmkvist T, Norbäck D, Meriläinen P, Högman M., 2006. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J 28:339–45.
27. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. 2005. General considerations for lung function testing. Eur Respir J 26:153–61.
28. NIOSH. 2013. Occupational Exposure to Carbon Nanotubes and Nanofibers.
29. Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, et al. 2011. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J 38:1019–28.
30. Powers CJ, McLeskey SW, Wellstein A., 2000. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7:165–97.
31. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC., 1993. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir Eur Respir J Suppl 16:5–40.
32. R Core Team. 2014. R:A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
33. Rades D, Seibold ND, Gebhard MP, Noack F, Bruchhage KL, Schild SE., 2014. Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck. Strahlentherapie Onkol Organ Dtsch Röntgengesellschaft [Et Al] 190:68–74.
34. Ricciardolo FLM., 2003. Multiple roles of nitric oxide in the airways. Thorax 58:175–82.
35. Rijcken B, Kerkhof M,D, Graaf A, Boezen HM, Droste JHJ, Kremer AM., 1996. Europees Luchtweg Onderzoek Nederland. Groningen:Rijksuniversiteit Groningen.
36. Salvi S, Blomberg A, Rudell B, Kelly F, Sandström T, Holgate ST, et al. 1999. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 159:702–9.
37. Schubauer-Berigan MK, Dahm MM, Yencken MS., 2011. Engineered carbonaceous nanomaterials manufacturers in the United States:workforce size, characteristics, and feasibility of epidemiologic studies. J Occup Environ Med 53:S62–S7.
38. Shah B, Sha D, Xie D, Mohler ER, Berger JS., 2012. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume:the National Health And Nutrition Examination Survey, 1999–2004. Diabetes Care 35:1074–8.
39. Shiels MS, Katki HA, Hildesheim A, Pfeiffer RM, Engels EA, Williams M, et al. 2015. Circulating inflammation markers, risk of lung cancer, and utility for risk stratification. J Natl Cancer Inst 107:djv199. doi:10.1093/jnci/djv199
40. Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park J-H, et al. 2013. Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst 105:1871–80.
41. Shvedova AA, Yanamala N, Kisin ER, Khailullin TO, Birch ME, Fatkhutdinova LM., 2016. Integrated analysis of dysregulated ncRNA and mRNA expression profiles in humans exposed to carbon nanotubes. PLoS One 11:e0150628.
42. Stark W, Stoessel P., 2015. Industrial applications of nanoparticles. Chem Soc Rev 44:5793–805.
43. Strak M, Hoek G, Godri KJ, Gosens I, Mudway IS, van Oerle R, et al. 2013. Composition of PM affects acute vascular inflammatory and coagulative markers–the RAPTES project. PLoS One 8:e58944.
44. Tromp P, Kuijpers E, Bekker C, Godderis L, Lan Q, Jedynska A, et al. 2017. A new approach combining analytical methods for workplace exposure assessment of inhalable multi-walled carbon nanotubes. Ann Occup Hygiene. (Under revision).
45. Van Amsterdam JG, Verlaan BP, Van Loveren H, Elzakker BG, Vos SG, Opperhuizen A, et al. 1999. Air pollution is associated with increased level of exhaled nitric oxide in nonsmoking healthy subjects. Arch Environ Health 54:331–5.
46. Wu W-T, Liao H-Y, Chung Y-T, Li W-F, Tsou T-C, Li L-A, et al. 2014. Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials. Int J Mol Sci 15:878–94.
47. Zuurbier M, Hoek G, Oldenwening M, Meliefste K, van den Hazel P, Brunekreef B., 2011. Respiratory effects of commuters' exposure to air pollution in traffic. Epidemiology 22:219–27.